Neuren Pharmaceuticals Limited (ASX:NEU) Directors Insider Transactions
The Directors and Chief Executives of Neuren Pharmaceuticals Limited (ASX:NEU) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Neuren Pharmaceuticals Limited's shares in the stock market. Below table shows the list of insider transactions as reported by Neuren Pharmaceuticals Limited to the ASX stock exchange.
An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.
Neuren Pharmaceuticals Limited Directors/Insider Transactions Activity
List of Insider trades activity from Neuren Pharmaceuticals Limited (NEU).
| Date | Director | Director's Title | Shares | Value | Note |
|---|---|---|---|---|---|
| 08 Sep 2025 | Pilcher (Jonathan) | Chief Executive Officer | 398,207 | 5,248,368 | Sale at price 13.18 per share. |
| 22 Jul 2025 | Pilcher (Jonathan) | Chief Executive Officer | 1,500,000 | 1,808,850 | Other at price 1.21 per share. |
| 16 Apr 2025 | Basile (Joseph) | Independent Non-Executive Director | 13,094 | 88,087 | Purchase at price 6.73 per share. |
| 31 Dec 2024 | Basile (Joseph) | Independent Non-Executive Director | 7,812 | - | - |
| 11 Jun 2024 | Basile (Joseph) | Independent Non-Executive Director | 5,000 | 64,414 | Purchase at price 12.88 per share. |